This topic contains a solution. Click here to go to the answer

Author Question: Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than ... (Read 101 times)

azncindy619

  • Hero Member
  • *****
  • Posts: 562
Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than an infusion of mycophenolate (CellCept)?
 
  a. Muromonab-CD3 is administered for shorter time periods than is mycophenolate.
  b. Muromonab-CD3 is administered in much higher dosages than is mycophenolate.
  c. Mycophenolate is an antiproliferative agent and muromonab-CD3 is a polyclonal antibody.
  d. Mycophenolate is a synthetically manufactured drug and muromonab-CD3 is produced using mouse proteins.

Question 2

Which precaution is most important to teach a patient taking an antiproliferative agent to manage an autoimmune disease?
 
  a. Do not stop taking this drug for any reason or your organs will become atrophied.
  b. Keep all health care appointments because your risk for cancer is now increased.
  c. Avoid foods and drinks containing caffeine because your risk for high blood pressure is greatly increased.
  d. Make certain someone is with you when you take this drug because allergic reactions are common and often delayed.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

alexanderhamilton

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

ANS: D

Answer to Question 2

ANS: B




azncindy619

  • Member
  • Posts: 562
Reply 2 on: Jul 23, 2018
:D TYSM


smrtceo

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library